Literature DB >> 7872775

Comparison of the effects of potassium on ouabain binding to native and site-directed mutants of Na,K-ATPase.

C L Johnson1, P J Schultheis, J B Lingrel, C G Johnson, E T Wallick.   

Abstract

We examined the effect of K+ on Mg(2+)- and P(i)-supported [3H]ouabain binding to Na,K-ATPases, including partially purified enzyme from sheep kidney and wild-type and mutant sheep alpha 1 isoforms (C104A, Y108A, E116Q, P118K, Y124F, R880P, R880L, and N122D) expressed in NIH3T3 cells. In the presence of increasing concentrations of K+, [3H]ouabain binding to these enzymes decreases but never reaches nonspecific binding levels, consistent with the concept that ouabain is still able to bind to the K(+)-complexed enzyme but with reduced affinity. A partially competitive model for K+ inhibition of ouabain binding is proposed which satisfactorily fits the binding data. The model is consistent with the sequential binding of two K+ ions to the enzyme. Ki values (approximately 1.0 mM) for K+ obtained from this model are comparable to the apparent K+ affinities of the rat alpha isoforms determined by measuring the K+ dependence of Na,K-ATPase activity [E. A. Jewell and J. B. Lingrel (1991) J. Biol. Chem. 266, 16925-16930]. This is consistent with the concept that K+ inhibition of Mg2+ plus P(i) supported ouabain binding is mediated by K+ binding to the same high-affinity binding sites present in the native enzyme under physiological conditions. While the mutants exhibit binding constants for ouabain which vary more than 30-fold from that of the wild-type enzyme, their affinities for K+ differ less than twofold from that of the native enzyme. Our results suggest that the ouabain and K+ binding sites are not the same and are differentially affected by mutations of the enzyme. The system described here should prove useful in the analysis of cation binding to other mutants of the Na,K-ATPase, especially those carrying amino acid replacements which result in an inactive enzyme.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7872775     DOI: 10.1006/abbi.1995.1145

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  4 in total

1.  The Administration of Levocabastine, a NTS2 Receptor Antagonist, Modifies Na(+), K(+)-ATPase Properties.

Authors:  Alicia Gutnisky; María Graciela López Ordieres; Georgina Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  2016-01-07       Impact factor: 3.996

2.  Isoform specificity of cardiac glycosides binding to human Na+,K+-ATPase alpha1beta1, alpha2beta1 and alpha3beta1.

Authors:  Christian Hauck; Tatjana Potter; Michaela Bartz; Thorsten Wittwer; Thorsten Wahlers; Uwe Mehlhorn; Georgios Scheiner-Bobis; Alicia A McDonough; Wilhelm Bloch; Robert H G Schwinger; Jochen Müller-Ehmsen
Journal:  Eur J Pharmacol       Date:  2009-09-12       Impact factor: 4.432

3.  Glutamic acid 327 in the sheep alpha 1 isoform of Na+,K(+)-ATPase is a pivotal residue for cation-induced conformational changes.

Authors:  C L Johnson; T A Kuntzweiler; J B Lingrel; C G Johnson; E T Wallick
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

4.  K⁺ and Rb⁺ Affinities of the Na,K-ATPase α₁ and α₂ Isozymes: An Application of ICP-MS for Quantification of Na⁺ Pump Kinetics in Myofibers.

Authors:  Hesamedin Hakimjavadi; Cory A Stiner; Tatiana L Radzyukevich; Jerry B Lingrel; Natalie Norman; Julio A Landero Figueroa; Judith A Heiny
Journal:  Int J Mol Sci       Date:  2018-09-12       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.